Plasma brain-derived neurotrophic factor in hemodialysis patients

International Journal of Medical Sciences

Volumn 9, Issue 9, 2012, Pages 772-777

  Shin, Seok Joon ^a   Yoon, Hye Eun ^a   Chung, Sungjin ^a   Kim, Yong Gu ^b   Kim, Dai Jin ^a  

^a The Catholic University of Korea   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Brain derived neurotrophic factor; Cytokine; Hemodialysis; Inflammation; Uremia

Indexed keywords

ALBUMIN; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA CLEARANCE; PROTEIN BLOOD LEVEL; TREATMENT DURATION; UREMIA;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-4; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RENAL DIALYSIS; TUMOR NECROSIS FACTOR-ALPHA; UREMIA;

EID: 84868533117     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5063     Document Type: Article

References (24)

1. Barbacid M. Neurotrophic factors and their receptors. Curr Opin Cell Biol. 1995; 7: 148-55.
2. Suwa M, Kishimoto H, Nofuji Y, et al. Serum brain-derived neurotrophic factor level is increased and associated with obesity in newly diagnosed female patients with type 2 diabetes mellitus. Metabolism. 2006; 55: 852-7.
3. Manni L, Nikolova V, Vyagova D, et al. Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. Int J Cardiol. 2005; 102: 169-71.
4. Grimsholm O, Rantapää-Dahlqvist S, Dalén T, et al. BDNF in RA: Downregulated in plasma following anti-TNF treatment but no correla tion with inflammatory parameters. Clin Rheumatol. 2008; 27: 1289-97.
5. Kim YK, Myint AM, Verkerk R, et al. Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients. Neuropsychobiology. 2009; 59: 123-9.
6. Laske C, Stransky E, Eschweiler GW, et al. Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants. J Psychiatr Res. 2007; 41: 600-5.
7. Dagnino-Subiabre A, Zepeda-Carreno R, Diaz-Veliz G, et al. Chronic stress induces upregulation of brain-derived neurotrophic factor (BDNF) mRNA and integrin alpha5 expression in the rat pineal gland. Brain Res. 2006; 1086: 27-34.
8. Kim DJ, Roh S, Kim Y, et al. High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users. Neurosci Lett. 2005; 388: 112-5.
9. Nakagawa T, Ogawa Y, Ebihara K, et al. Anti-obesity and anti-diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance. Int J Obes Relat Metab Disord. 2003; 27: 557-65.
10. Tonra JR, Ono M, Liu X, et al. Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Diabetes. 1999; 48: 588-94.
11. Tsuchida A, Nonomura T, Nakagawa T, et al. Brain-derived neurotrophic factor ameliorates lipid metabolism in diabetic mice. Diabetes Obes Metab. 2002; 4: 262-9.
12. Duan W, Guo Z, Jiang H, et al. Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. Endocrinology. 2003; 144: 2446-53.
13. Fujinami A, Ohta K, Obayashi H, et al. Serum brain-derived neu rotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistance. Clin Biochem. 2008; 41: 812-7.
14. Dogliotti G, Galliera E, Licastro F, et al. Age-related changes in plasma levels of BDNF in Down syndrome patients. Immun Ageing. 2010; 7: 2.
15. Cohen SD, Phillips TM, Khetpal P, et al. Cytokine patterns and survival in haemodialysis patients. Nephrol Dial Transplant. 2010; 25: 1239-43.
16. Oddiah D, Anand P, McMahon SB, et al. Rapid increase of NGF, BDNF and NT-3 mRNAs in inflamed bladder. Neuroreport. 1998; 9: 1455-8.
17. Hahn C, Islamian AP, Renz H, et al. Airway epithelial cells produce neurotrophins and promote the survival of eosinophils during allergic airway inflammation. J Allergy Clin Immunol. 2006; 117: 787-94.
18. Kerschensteiner M, Gallmeier E, Behrens L, et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med. 1999; 189: 865-70.
19. Pereira R, Costa E, Gonçalves M, et al. Neutrophil and monocyte activa tion in chronic kidney disease patients under hemodialysis and its relationship with resistance to recombinant human erythropoietin and to the hemodialysis procedure. Hemodial Int. 2010; 14: 295-301.
20. Fujimura H, Altar CA, Chen R, et al. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost. 2002; 87: 728-34.
21. Rosenfeld RD, Zeni L, Haniu M, et al. Purification and identification of brain-derived neurotrophic factor from human serum. Protein Expr Purif. 1995; 6: 465-71.
22. Chula BL, Choia I, Kim YK, et al. Relation between plasma brain-derived neurotrophic factor and nerve growth factor in the male patients with alcohol dependence. Alcohol. 2009; 43: 265-9.
23. Nofuji Y, Suwa M, Sasaki H, et al. Different circulating brain-derived neurotrophic factor responses to acute exercise between physically active and sedentary subjects. J Sports Sci Med. 2012; 11: 83-8.
24. Piccinni A, Marazziti D, Catena M, et al. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord. 2008; 105: 279-83.